Skip to content

Clinical trials

Phase 2/3 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20131
20141
20161
20201
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Withdrawn2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Asociación para Evitar la Ceguera en México1
BCN Peptides1
Damascus University1
Isfahan Ophthalmology Research Center1
Isfahan University of Medical Sciences1
Marashi Eye Clinic1
Peter Rossing1
University of California, San Francisco1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy11
Diabetes Mellitus3
Macular Edema3
Diabetes Mellitus, Type 22
Cataract1
Diabetes Complications1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1
Renal Insufficiency, Chronic1
Retinal Neovascularization1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.